Docmode Health

When is the next results date for Docmode Health?

No Upcoming Board Meetings

Has Docmode Health declared dividend?

No Dividend History Available

Who are the peers of the Docmode Health?

Docmode Health's peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Aster DM Health, Krishna Institu, Rainbow Child, Dr Agarwal's Health, and Broach. Max Healthcare and Apollo Hospitals show excellent growth and management, while Docmode Health has a 1-year return of 0.00%.

Peers: The peers of Docmode Health are Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, Aster DM Health, Krishna Institu, Rainbow Child, Dr Agarwal's Hea, and Broach.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Global Health, Krishna Institu, Rainbow Child, and Dr Agarwal's Hea, while Average management risk is found at Fortis Health, Aster DM Health, and Broach. Growth is excellent at Max Healthcare and Apollo Hospitals, good at Fortis Health, Narayana Hrudaya, and Dr Agarwal's Hea, while below average growth is noted at Aster DM Health, Krishna Institu, Rainbow Child, and Broach. Capital structure is excellent at Max Healthcare, Global Health, and Krishna Institu, good at Fortis Health, Narayana Hrudaya, Rainbow Child, and Broach, while below average capital structure is seen at Aster DM Health, Docmode Health, and the rest.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Krishna Institu at 85.24%, while the lowest is Dr Agarwal's Hea and Broach, both with N/A returns, and Docmode Health's own 1-year return is 0.00%. Additionally, Aster DM Health and Broach have negative six-month returns.

Is Docmode Health overvalued or undervalued?

As of June 2, 2025, Docmode Health is classified as risky and overvalued, with a PE ratio of -10.42 and a year-to-date return of -23.83%, significantly underperforming compared to its peers and the Sensex.

As of 2 June 2025, the valuation grade for Docmode Health has moved from does not qualify to risky. The company is currently assessed as overvalued. Key ratios indicate significant financial distress, with a PE ratio of -10.42, an EV to EBIT of -27.08, and a ROE of -19.55%. <BR><BR>In comparison to its peers, Docmode Health's valuation metrics are starkly unfavorable; for instance, Veranda Learning, also classified as risky, has a PE ratio of 165.27, while Shanti Educational Initiatives Ltd. is deemed very expensive with a PE ratio of 199.65. The recent stock performance shows a significant decline, with a year-to-date return of -23.83%, contrasting sharply with the Sensex's gain of 6.24% during the same period, further reinforcing the overvaluation narrative.

What is the technical trend for Docmode Health?

As of June 2, 2025, Docmode Health's trend has shifted to mildly bearish due to daily moving averages indicating bearish momentum, despite some underlying strength from weekly MACD and a neutral outlook from Dow Theory.

As of 2 June 2025, the technical trend for Docmode Health has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating bearish momentum. The weekly MACD remains mildly bullish, suggesting some underlying strength, but the overall trend is tempered by the daily indicators. The RSI shows no signal across both weekly and monthly time frames, indicating a lack of momentum. Additionally, the Dow Theory shows no trend in both weekly and monthly perspectives, further supporting a neutral outlook. Overall, while there are some bullish signals in the weekly indicators, the prevailing daily bearish trend suggests caution.

What does Docmode Health do?

Docmode Health Technologies Ltd is a micro-cap company in the hospital industry, incorporated in 2017 and converted to a public limited company in 2023. It currently has no reported sales or profits, with a market cap of INR 15 Cr.

Overview: <BR>Docmode Health Technologies Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Docmode Health Technologies Ltd was incorporated on July 17, 2017, and was initially registered as a private limited company. It later converted to a public limited company, with the name change taking effect on January 2, 2023. There is no recent sales or profit data reported.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 15 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.57 <BR>Return on Equity: -19.55% <BR>Price-to-Book: 1.41 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

Who are the top shareholders of the Docmode Health?

The top shareholders of Docmode Health include Paulson Paul Thazhathedath, who holds 23.71%, and individual investors who collectively own 48.97%. There are no mutual funds or foreign institutional investors involved, and pledged promoter holdings are at 61.1641%.

The top shareholders of Docmode Health primarily consist of non-institutional investors. The promoter with the highest holding is Paulson Paul Thazhathedath, who owns 23.71% of the company. Additionally, individual investors collectively hold 48.97% of the shares. There are no mutual funds or foreign institutional investors currently holding shares in the company. The pledged promoter holdings stand at 61.1641%.

How big is Docmode Health?

As of 23rd July, Docmode Health Technologies Ltd has a market capitalization of 16.00 Cr, classified as a Micro Cap, with no available financial data for Net Sales or Net Profit for the latest four quarters. The balance sheet as of March 2024 shows Shareholder's Funds of 10.37 Cr and Total Assets of 26.21 Cr.

As of 23rd July, <BR><BR>Market Cap: Docmode Health Technologies Ltd has a market capitalization of 16.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales or Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 10.37 Cr and Total Assets valued at 26.21 Cr.

How has been the historical performance of Docmode Health?

Docmode Health has experienced significant sales growth from 12.42 Cr in March 2022 to 41.77 Cr in March 2025, but rising expenditures have led to negative operating profit and losses in profit before and after tax, with EPS dropping to -6.46. Total assets and liabilities have increased to 39.06 Cr by March 2025, while cash flow remains tight.

Answer:<BR>The historical performance of Docmode Health shows a fluctuating trend in key financial metrics over the past four fiscal years.<BR><BR>Breakdown:<BR>Docmode Health's net sales have increased from 12.42 Cr in March 2022 to 41.77 Cr in March 2025, indicating a strong growth trajectory. However, the total expenditure has also risen significantly, from 10.54 Cr in March 2022 to 42.45 Cr in March 2025, leading to an operating profit (PBDIT) that turned negative at -0.68 Cr in March 2025, down from a positive 3.75 Cr in March 2023. Consequently, the profit before tax has declined sharply to -1.97 Cr in March 2025, compared to 2.69 Cr in March 2023. The profit after tax mirrored this decline, falling to -2.03 Cr in March 2025 from 1.95 Cr in March 2023. The company's earnings per share (EPS) also reflect this downturn, dropping to -6.46 in March 2025 from 8.52 in March 2023. On the balance sheet, total assets have increased from 10.01 Cr in March 2022 to 39.06 Cr in March 2025, while total liabilities have also risen from 10.01 Cr to 39.06 Cr in the same period. Cash flow from operating activities improved to 4.00 Cr in March 2024, but the overall cash flow situation remains tight with a closing cash equivalent of 3.00 Cr in March 2024.

Why is Docmode Health Technologies Ltd falling/rising?

As of 26-May, Docmode Health Technologies Ltd's stock price is stable at 51.00, with a recent positive trend showing a 4.94% increase over the past week and 15.65% over the past month. However, year-to-date, the stock has declined by 28.47%, indicating significant long-term challenges despite short-term gains and increased investor interest.

As of 26-May, Docmode Health Technologies Ltd's stock price is currently stable at 51.00, with no change recorded (0.00%). However, the stock has shown a positive trend over the past week and month, outperforming the benchmark Sensex. Specifically, the stock has increased by 4.94% over the past week and 15.65% over the past month, while the Sensex has only risen by 1.25% and 0.07%, respectively. <BR><BR>Despite these recent gains, the year-to-date performance indicates a significant decline of 28.47%, which is notably worse than the Sensex's decline of 8.48%. Additionally, the stock has a one-year decline of 21.36%, compared to the Sensex's decline of 4.35%. <BR><BR>Today's performance summary indicates that the stock has outperformed its sector by 0.53%, and there has been a notable increase in investor participation, with delivery volume rising by 25% against the five-day average. The stock is also trading above its five-day, twenty-day, and fifty-day moving averages, although it remains below the one hundred-day and two hundred-day moving averages. <BR><BR>Overall, while the stock is currently stable, the recent upward movements in the short term, coupled with increased investor participation, suggest a potential positive sentiment among investors, despite the longer-term declines.

Which are the latest news on Docmode Health?